A UB MD/PhD candidate is lead author on a paper describing how drug-resistant viruses may be thwarted by a potent, immune-boosting payload delivered to cells by gold nanorods.
A group of young entrepreneurs led by Krishnan Chakravarthy, an MD/PhD candidate in the school’s MD-PhD Program, has launched NanoAxis, a new research and development company headquartered in Getzville, New York.
